Nykredit A S Invests $140.59 Million in Gilead Sciences, Inc. $GILD

Nykredit A/S has acquired a significant new position in Gilead Sciences, Inc. (NASDAQ:GILD), purchasing over 1.11 million shares valued at approximately $140.59 million during the second quarter. This investment highlights continued institutional interest in the biopharmaceutical company, which has seen its revenue grow by 10.6% year-over-year and recently expanded its HIV prevention licensing agreements to 120 high-incidence countries. Despite some insider selling, analysts maintain a "Moderate